Biotech news
Europe
Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and inventive step evaluation. 26 June 2025
Americas
This panel brings together experts from Wolf Greenfield, BlueRock Therapeutics, BioNTech, and Generate Biomedicines to explore the evolving landscape of pharmaceutical collaborations. The discussion focuses on how partnerships can accelerate drug discovery, share risks, and pool resources in today’s complex drug development environment. 25 June 2025
Americas
The biotech firm strikes again over Eylea after Amgen launches biosimilar | Regeneron claims Amgen infringed agreed ‘patent dance’ | Follows other lawsuits aimed at protecting Eylea. 19 June 2025
Europe
Court affirms infringement of patent covering gene expression technology | Curio Bioscience cannot sell related products in three EU countries | Decision is “further testament to 10x Genomic’s strategic use of IP”, 10x counsel tells LSIPR. 17 June 2025
Americas
Office’s acting director lifts severe penalties against patent owner following Federal Circuit remand | Issues separate decision highlighting consequences of “lengthy awareness” of patent portfolio. 10 June 2025
Americas
New York court finds Ethicon breached agreement with ChemImage over advanced imaging technologies | Parties dispute damages for IP ‘impairment’. 3 June 2025
Careers
The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular biology and medical technologies. 3 June 2025
Americas
Ravi Srinivasan of JA Kemp explores strategies for identifying, prosecuting, and defending follow-on patent applications after a therapeutic product enters the public domain. The session at LSPN covers patents based on clinical trial data and polymorphs of small molecule drugs. 29 May 2025
Careers
New hire is a specialist in pharmaceutical regulatory matters, complex patent disputes, and cross-border transactional support for biotech. 27 May 2025
Europe
Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis. 22 May 2025